Life Sciences
Our cross-border, multidisciplinary team brings unique market awareness and a business-minded approach to players in the life sciences industry.
Life Sciences

Overview

Torys’ Life Sciences practice is the only Canadian practice to be consistently ranked in Band 1 by Chambers and Partners and is recognized for transactional strength and broad IP capabilities. Our team includes over 40 lawyers and patent agents, including PhDs, MScs and engineers. It is this sophisticated capability that facilitates the pragmatic and innovative counsel we give to clients across the life sciences ecosystem.

We serve biotech, pharmaceutical, medical device and health technology companies on all aspects of their business. With full-service capabilities on both sides of the Canada-U.S. border, we are uniquely positioned to advise organizations as a single firm on cross-border transactions.

Primary Contact

View All Team Members

Areas of Service

  • Intellectual Property
    We advise on the protection and commercial exploitation of IP rights, and ongoing management of patents and trademarks, including those related to the collection and use of data, diagnostics and other pharma-related services.
    Learn more
  • Food and Drug
    Our team regularly advises on regulatory compliance and marketing, including advertising and pricing matters, Food and Drugs Act compliance, trade, pricing, and cross-border digital sales issues.
    Learn more
  • M&A
    Our leading M&A team provides multidisciplinary, sophisticated advice in the sector’s most complex and significant transactions, domestically and internationally.
    Learn more
  • Capital Markets
    We give clients tailored solutions to access the capital markets on both sides of the Canada-U.S. border, offering an integrated, one-firm approach to domestic and cross-border offerings.
    Learn more
  • Emerging Companies and VC
    We help life sciences startups to protect inventions, commercialize, and establish business structures. We also assist with their licensing, financing and M&A work, and help investors in the sector realize their investment strategies.
    Learn more
  • Intellectual Property Litigation
    Our team partners with clients in protecting, enforcing and licensing IP rights, including patents. We manage complex matters, acting for clients in disputes before all levels of courts, IP tribunals and regulatory bodies.
    Learn more
  • Pharma and Biotech
    We advise on regulatory, privacy and pricing issues; drafting and negotiating agreements; consents for both the use of data or biological materials in research and for clinical trials; and product approvals and product launches.
  • Cannabis
    We have broad experience in the cannabis ecosystem—from compliance, production and IP advice, to financing, M&A and governance. Our clients span the sector and include licensed producers, researchers and developers.
    Learn more
We are recognized for exceptional depth of industry experience and uncompromising client service for all players in the sector. 
We know how to drive growth.
We help emerging companies scale and thrive. We have advised on Series A financings totaling over $1B in the last three years.
We work with industry leaders. 
Our cross-border team is longstanding counsel to 12 of the world’s top 20 medical device companies, and 14 of the world’s top 20 pharmaceutical companies.
>$1B
Series A financings in the last three years
14/20
Top pharma companies
12/20
Top devices companies

Featured Work

Representative Work

They're very experienced in the biopharmaceuticals and healthcare area and we get a very tailored service. They always deliver results, no matter how tight the timeline is.
— Chambers Canada, 2023
View all

Recent Recognition

View all

Related Services

Subscribe and stay informed

Stay in the know. Get the latest commentary, updates and insights for business from Torys.

Subscribe Now
TwitterLinkedIn